Le produit a bien été ajouté au panier.

discount label
H-EIYKRWII^-OH
Vue en 3D

Biosynth logo

H-EIYKRWII^-OH

Ref. 3D-PP48821

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mercredi 6 novembre 2024

Informations sur le produit

Nom :
H-EIYKRWII^-OH
Description :

Peptide H-EIYKRWII^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EIYKRWII^-OH include the following: Compartmentalized CD8+ T cell repertoires of the male genital tract in chronic HIV infection WMP Coston - 2003 - search.proquest.comhttps://search.proquest.com/openview/a339627bc650cda4db1b8cc03aaeb4d8/1?pq-origsite=gscholar&cbl=18750&diss=y The Antiviral Efficacy of HIV-Specific CD8+ T-Cells to a Conserved Epitope Is Heavily Dependent on the Infecting HIV-1 Isolate SRF Ranasinghe, HB Kramer, C Wright - PLoS , 2011 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1001341 Persistent numbers of tetramer+ CD8+ T cells, but loss of interferon-γ+ HIV-specific T cells during progression to AIDS S Kostense , K Vandenberghe, J Joling - Blood, The Journal , 2002 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/99/7/2505/106719 High viral burden in the presence of major HIV-specific CD8+ T cell expansions: evidence for impaired CTL effector function S Kostense , GS Ogg , EH Manting - European journal of , 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200103)31:3%3C677::AID-IMMU677%3E3.0.CO;2-M Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes PJR Goulder , SW Reid, DA Price - European journal of , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830270630 On the feasibility of mining CD8+ T cell receptor patterns underlying immunogenic peptide recognition N De Neuter , W Bittremieux , C Beirnaert , B Cuypers - Immunogenetics, 2018 - Springerhttps://link.springer.com/article/10.1007/s00251-017-1023-5 Machine learning for decision support in adaptive immunology N De Neuter - 2019 - repository.uantwerpen.behttps://repository.uantwerpen.be/link/irua/167047 HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-γ and tumor necrosis factor-alpha M Lichterfeld, XUG Yu , MT Waring, SK Mui - Blood, 2004 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/104/2/487/18313 Supplemental Table 1. List of HIV class I peptides. M End - pdfs.semanticscholar.orghttps://pdfs.semanticscholar.org/ed0f/0f087694817c860c5aad97fab618403c2847.pdf Role of cytotoxic T-lymphocyte-mediated immune selection in a dominant human leukocyte antigen-B8-restricted cytotoxic T-lymphocyte epitope in Nef K Maurer, EG Harrer, A Goldwich - JAIDS Journal of , 2008 - journals.lww.comhttps://journals.lww.com/jaids/fulltext/2008/06010/Role_of_Cytotoxic_T_Lymphocyte_Mediated_Immune.3.aspx Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy JP Casazza, MR Betts , BJ Hill, JM Brenchley - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.6.3653-3663.2005 CD8+ Cytotoxic T Lymphocyte Responses and Viral Epitope Escape in Acute HIV-1 Infection J Kim, J De La Cruz, K Lam, H Ng, ES Daar - Viral , 2018 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/vim.2018.0040 Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1-Specific CD8+ T Cells H Streeck, ZL Brumme , M Anastario, KW Cohen - PLoS , 2008 - journals.plos.orghttps://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0050100 Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8+ T-Cell Subsets E Veel, L Westera, R Van Gent, L Bont , S Otto - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.00572/full Lack of Epstein-Barr virus-and HIV-specific CD27-CD8+ T cells is associated with progression to viral disease in HIV-infection D van Baarle , S Kostense , E Hovenkamp, G Ogg - Aids, 2002 - journals.lww.comhttps://journals.lww.com/aidsonline/fulltext/2002/10180/lack_of_epstein_barr_virus__and_hiv_specific_cd27_.4.aspx Longitudinal changes in HIV-1-specific T-cell quality associated with viral load dynamic CJ Dembek, S Kutscher, S Allgayer, C Russo - Journal of clinical , 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1386653212002430 High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection CA Jansen, S Kostense - European journal of , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200425487 Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation CA Jansen, CWA Cruijsen, T de Ruiter - European journal of , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200636678 GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy C Gubser , RD Pascoe, J Chang, C Chiu, A Solomon - Iscience, 2023 - cell.comhttps://www.cell.com/iscience/pdf/S2589-0042(23)02242-3.pdf Linear B-cell epitopes of the major core protein of human immunodeficiency virus types 1 and 2 B Janvier, P Archinard, B Mandrand - Journal of , 1990 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.64.9.4258-4263.1990 Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine A Lopez, N van der Lubbe, S Sanchez-Palomino - Vaccine, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X09011979

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP48821 H-EIYKRWII^-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".